292 related articles for article (PubMed ID: 23998397)
1. Efficacy and safety of pregabalin in patients with spinal cord injury: a pooled analysis.
Parsons B; Sanin L; Yang R; Emir B; Juhn M
Curr Med Res Opin; 2013 Dec; 29(12):1675-83. PubMed ID: 23998397
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and tolerability of pregabalin using a flexible, optimized dose schedule in Korean patients with peripheral neuropathic pain: a 10-week, randomized, double-blind, placebo-controlled, multicenter study.
Moon DE; Lee DI; Lee SC; Song SO; Yoon DM; Yoon MH; Kim HK; Lee YW; Kim C; Lee PB
Clin Ther; 2010 Dec; 32(14):2370-85. PubMed ID: 21353106
[TBL] [Abstract][Full Text] [Related]
3. Pregabalin in central neuropathic pain associated with spinal cord injury: a placebo-controlled trial.
Siddall PJ; Cousins MJ; Otte A; Griesing T; Chambers R; Murphy TK
Neurology; 2006 Nov; 67(10):1792-800. PubMed ID: 17130411
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of pregabalin for peripheral neuropathic pain: results of an 8-week, flexible-dose, double-blind, placebo-controlled study conducted in China.
Guan Y; Ding X; Cheng Y; Fan D; Tan L; Wang Y; Zhao Z; Hong Z; Zhou D; Pan X; Chen S; Martin A; Tang H; Cui L
Clin Ther; 2011 Feb; 33(2):159-66. PubMed ID: 21444113
[TBL] [Abstract][Full Text] [Related]
5. Pregabalin for relief of neuropathic pain associated with diabetic neuropathy: a randomized, double-blind study.
Tölle T; Freynhagen R; Versavel M; Trostmann U; Young JP
Eur J Pain; 2008 Feb; 12(2):203-13. PubMed ID: 17631400
[TBL] [Abstract][Full Text] [Related]
6. A prospective, open-label, multicentre study of pregabalin in the treatment of neuropathic pain in Latin America.
Xochilcal-Morales M; Castro EM; Guajardo-Rosas J; Obregón TN; Acevedo JC; Chucan JM; Plancarte-Sanchez R; Davila G; Wajsbrot D; Guerrero M; Vinueza R
Int J Clin Pract; 2010 Aug; 64(9):1301-9. PubMed ID: 20487048
[TBL] [Abstract][Full Text] [Related]
7. A randomized, double-blind, placebo-controlled, phase III trial of pregabalin in the treatment of patients with fibromyalgia.
Mease PJ; Russell IJ; Arnold LM; Florian H; Young JP; Martin SA; Sharma U
J Rheumatol; 2008 Mar; 35(3):502-14. PubMed ID: 18278830
[TBL] [Abstract][Full Text] [Related]
8. Pregabalin reduces pain and improves sleep and mood disturbances in patients with post-herpetic neuralgia: results of a randomised, placebo-controlled clinical trial.
Sabatowski R; Gálvez R; Cherry DA; Jacquot F; Vincent E; Maisonobe P; Versavel M;
Pain; 2004 May; 109(1-2):26-35. PubMed ID: 15082123
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and tolerability of twice-daily pregabalin for treating pain and related sleep interference in postherpetic neuralgia: a 13-week, randomized trial.
van Seventer R; Feister HA; Young JP; Stoker M; Versavel M; Rigaudy L
Curr Med Res Opin; 2006 Feb; 22(2):375-84. PubMed ID: 16466610
[TBL] [Abstract][Full Text] [Related]
10. 5% lidocaine medicated plaster versus pregabalin in post-herpetic neuralgia and diabetic polyneuropathy: an open-label, non-inferiority two-stage RCT study.
Baron R; Mayoral V; Leijon G; Binder A; Steigerwald I; Serpell M
Curr Med Res Opin; 2009 Jul; 25(7):1663-76. PubMed ID: 19485723
[TBL] [Abstract][Full Text] [Related]
11. The efficacy of pregabalin in patients with moderate and severe pain due to diabetic peripheral neuropathy.
Parsons B; Li C
Curr Med Res Opin; 2016 May; 32(5):929-37. PubMed ID: 26854578
[TBL] [Abstract][Full Text] [Related]
12. A randomized trial of pregabalin in patients with neuropathic pain due to spinal cord injury.
Cardenas DD; Nieshoff EC; Suda K; Goto S; Sanin L; Kaneko T; Sporn J; Parsons B; Soulsby M; Yang R; Whalen E; Scavone JM; Suzuki MM; Knapp LE
Neurology; 2013 Feb; 80(6):533-9. PubMed ID: 23345639
[TBL] [Abstract][Full Text] [Related]
13. Pregabalin or placebo used adjunctively with levetiracetam in refractory partial-onset epilepsy: a post hoc efficacy and safety analysis in combined clinical trials.
Uthman BM; Almas M; Emir B; Giordano S; Leon T
Curr Med Res Opin; 2011 Jul; 27(7):1285-93. PubMed ID: 21561392
[TBL] [Abstract][Full Text] [Related]
14. A 14-week, randomized, double-blinded, placebo-controlled monotherapy trial of pregabalin in patients with fibromyalgia.
Arnold LM; Russell IJ; Diri EW; Duan WR; Young JP; Sharma U; Martin SA; Barrett JA; Haig G
J Pain; 2008 Sep; 9(9):792-805. PubMed ID: 18524684
[TBL] [Abstract][Full Text] [Related]
15. Pregabalin: a novel gamma-aminobutyric acid analogue in the treatment of neuropathic pain, partial-onset seizures, and anxiety disorders.
Tassone DM; Boyce E; Guyer J; Nuzum D
Clin Ther; 2007 Jan; 29(1):26-48. PubMed ID: 17379045
[TBL] [Abstract][Full Text] [Related]
16. An international, randomized, double-blind, placebo-controlled, phase III trial of pregabalin monotherapy in treatment of patients with fibromyalgia.
Pauer L; Winkelmann A; Arsenault P; Jespersen A; Whelan L; Atkinson G; Leon T; Zeiher B;
J Rheumatol; 2011 Dec; 38(12):2643-52. PubMed ID: 21965636
[TBL] [Abstract][Full Text] [Related]
17. Pregabalin for peripheral neuropathic pain: a multicenter, enriched enrollment randomized withdrawal placebo-controlled trial.
Gilron I; Wajsbrot D; Therrien F; Lemay J
Clin J Pain; 2011; 27(3):185-93. PubMed ID: 21178603
[TBL] [Abstract][Full Text] [Related]
18. Safety profile and tolerability of up to 1 year of pregabalin treatment in 3 open-label extension studies in patients with fibromyalgia.
Arnold LM; Emir B; Murphy TK; Zeiher BG; Pauer L; Scott G; Petersel D
Clin Ther; 2012 May; 34(5):1092-102. PubMed ID: 22503162
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of combination therapy with 5% lidocaine medicated plaster and pregabalin in post-herpetic neuralgia and diabetic polyneuropathy.
Baron R; Mayoral V; Leijon G; Binder A; Steigerwald I; Serpell M
Curr Med Res Opin; 2009 Jul; 25(7):1677-87. PubMed ID: 19480610
[TBL] [Abstract][Full Text] [Related]
20. Relief of painful diabetic peripheral neuropathy with pregabalin: a randomized, placebo-controlled trial.
Richter RW; Portenoy R; Sharma U; Lamoreaux L; Bockbrader H; Knapp LE
J Pain; 2005 Apr; 6(4):253-60. PubMed ID: 15820913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]